Background: Mycoplasma pneumoniae is a well
known causative agent of infection in childhood but clinical
presentation may be variable. History and physical examination may not
be so helpful for the diagnosis. It is difficult to culture this
infectious agent, with the culture technique for the multiplication of
the organism for routine investigation hard to obtain. The determination
of exposure and prevalence of the disease of any region should be
helpful for clinical diagnosis. In this study, we aimed to determine the
seroprevalence of M. pneumoniae in children aged 014
years in Diyarbakir and establish the distribution of infection
prevalence of various age groups of children.
Methods: Thirty streets were determined according to
the cluster method for the 06
years age group. In this age group, a total of 180 blood samples were
collected; so that there were 30 samples for each age. For children aged
714
years, elementary school children were selected. There were 70
elementary schools in the city and 14 schools were randomly selected
according to the randomized numbers table with a 20% sample. Finally,
276 blood samples were collected. Mycoplasma pneumoniae was
determined by using the enzyme immunoassay method. For this method
MELOTEST Mycoplasma IgG reagent was used.
Results: The highest seropositivity rate was
encountered at 10 years of age (65%) and lowest was at 2 years of age
(0%). The overall M. pneumoniae seropositivity was 27% when all
ages were considered together. The first 2 years of age excluded this
rate and was 31.9%. A sudden increase of seropositivity was observed at
7 years of age.
Conclusions: Increasing seroprevalence rates of M.
pneumoniae after 2 years of age should alert clinicians to consider
the organism in the differential diagnosis of infectious diseases in
this age group. The low seroprevalence rates in the first 2 years of age
was thought to be due to low risk of community-based spread of the
organism in this age group. The most prominent increase in
seroprevalence was at 10 years of age. This data indicated that M.
pneumoniae should be kept in mind while making differential
diagnosis of infections. The spreading of disease and community-based
transmission is also important to consider. In our study, seroprevalence
rates increased at 6 and 7 years of age, at the beginning of the school
age as community-based transmission takes place most commonly in crowded
circumstances. In conclusion, M. pneumoniae should be thought as
an important infectious agent in childhood for all age groups.
QuickSearch in:
for
Authors:
Mehmet
Bosnak,
Bunyamin
Dikici,
Vuslat
Bosnak,
Omer
Dogru,
Ilker
Ozkan,
Ali
Ceylan
Kenan
Haspolat
Key words
child
Mycoplasma
pneumoniae
prevalence
Affiliations
Departments of 1Pediatrics,
2Infectious Diseases and
3Public Health, Dicle University Medical
School, Diyarbakir, Turkey
Correspondence
Correspondence: Mehmet
Bosnak MD, Dicle Universitesi, Tip
Fakultesi, Cocuk Sagligi ve Hastaliklari Anabilim Dali, Diyarbakir,
Turkey. Email: mbosnak@dicle.edu.tr
To cite this article Bosnak, Mehmet, Dikici, Bunyamin, Bosnak, Vuslat,
Dogru, Omer, Ozkan, Ilker, Ceylan, Ali & Haspolat, Kenan
Prevalence of Mycoplasma pneumoniae in children in Diyarbakir,
the south-east of Turkey. Pediatrics International44 (5), 510-512. doi: 10.1046/
j.1442-200X.2002.01606.x
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"